ARTICLES:

A Delaunois, P Gustin, and M Ansay

Endogenous nitric oxide modulates acetylcholine-induced edema and vasoconstriction in isolated perfused rabbit lungs
J Pharmacol Exp Ther 1995 274: 559-597. [Abstract]  

A. DELAUNOIS, P. GUSTIN, and M. ANSAY

Endogenous Nitric Oxide Modulates Acetylcholine-induced Edema and Vasoconstriction in Isolated Perfused Rabbit Lungs
J Pharmacol Exp Ther 1995 274: 589-597. [Abstract] [PDF]  

MA Carlisle, DD Smyth, and GB Glavin

Efaroxan acts peripherally to block the antisecretory and gastroprotective effects of moxonidine in rats
J Pharmacol Exp Ther 1995 274: 598-601. [Abstract] [PDF]  

Y Matsuoka, H Hasegawa, S Okuda, T Muraki, T Uruno, and K Kubota

Ameliorative effects of tea catechins on active oxygen-related nerve cell injuries
J Pharmacol Exp Ther 1995 274: 602-608. [Abstract] [PDF]  

CW Aretha, A Sinha, and MP Galloway

Dopamine D3-preferring ligands act at synthesis modulating autoreceptors
J Pharmacol Exp Ther 1995 274: 609-613. [Abstract] [PDF]  

P Clausing, B Gough, RR Holson, W Jr Slikker, and JF Bowyer

Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects
J Pharmacol Exp Ther 1995 274: 614-621. [Abstract] [PDF]  

G Lhoest, RK Verbeeck, N Maton, P Muthelet, and D Latinne

The in vitro immunosuppressive activity of the C15-demethylated metabolite of FK-506 is governed by ring- and open-chain tautomerism effects
J Pharmacol Exp Ther 1995 274: 622-626. [Abstract] [PDF]  

J Utz, R Eckert, and W Trautwein

Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors
J Pharmacol Exp Ther 1995 274: 627-633. [Abstract] [PDF]  

M Delaforge, A Piffeteau, JL Boucher, and A Viger

Nitric oxide formation during the cytochrome P-450-dependent reductive metabolism of 18-nitro-oxyandrostenedione
J Pharmacol Exp Ther 1995 274: 634-640. [Abstract] [PDF]  

MR Briejer, GJ Veen, LM Akkermans, RA Lefebvre, and JA Schuurkes

Cisapride and structural analogs selectively enhance 5- hydroxytryptamine (5-HT)-induced purinergic neurotransmission in the guinea pig proximal colon
J Pharmacol Exp Ther 1995 274: 641-648. [Abstract] [PDF]  

A Guia, N Leblanc, and R Bose

Effects of phenamil on potassium and calcium channels of guinea pig ventricular myocytes
J Pharmacol Exp Ther 1995 274: 649-656. [Abstract] [PDF]  

KM Kantak, MA Edwards, and RD Spealman

Effects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: comparison with direct and indirect dopamine agonists
J Pharmacol Exp Ther 1995 274: 657-665. [Abstract] [PDF]  

WH Xiao and GJ Bennett

Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats
J Pharmacol Exp Ther 1995 274: 666-672. [Abstract] [PDF]  

AP Li, A Rasmussen, L Xu, and DL Kaminski

Rifampicin induction of lidocaine metabolism in cultured human hepatocytes
J Pharmacol Exp Ther 1995 274: 673-677. [Abstract] [PDF]  

CD Nicholson, M Shahid, J Bruin, E Barron, I Spiers, J de Boer, RG van Amsterdam, J Zaagsma, JJ Kelly, and G Dent

Characterization of ORG 20241, a combined phosphodiesterase IV/III cyclic nucleotide phosphodiesterase inhibitor for asthma
J Pharmacol Exp Ther 1995 274: 678-687. [Abstract] [PDF]  

S Shibata, M Ono, N Fukuhara, and S Watanabe

Involvement of dopamine, N-methyl-D-aspartate and sigma receptor mechanisms in methamphetamine-induced anticipatory activity rhythm in rats
J Pharmacol Exp Ther 1995 274: 688-694. [Abstract] [PDF]  

Y Yano, A Hiraoka, and T Oguma

Enhancement of tobramycin binding to rat renal brush border membrane by vancomycin
J Pharmacol Exp Ther 1995 274: 695-699. [Abstract] [PDF]  

J Kamei, M Ohsawa, A Saitoh, Y Iwamoto, T Suzuki, M Misawa, H Nagase, and Y Kasuya

Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes
J Pharmacol Exp Ther 1995 274: 700-706. [Abstract] [PDF]  

JH 3rd Graham, JR Maher, and SE Robinson

The effect of cocaine and other local anesthetics on central dopaminergic neurotransmission
J Pharmacol Exp Ther 1995 274: 707-717. [Abstract] [PDF]  

LS Premkumar and GP Ahern

Blockade of a resting potassium channel and modulation of synaptic transmission by ecstasy in the hippocampus
J Pharmacol Exp Ther 1995 274: 718-722. [Abstract] [PDF]  

JH Sheldon and TM Argentieri

Acute administration of 17 beta-estradiol inhibits calcium currents in isolated guinea pig detrusor myocytes
J Pharmacol Exp Ther 1995 274: 723-729. [Abstract] [PDF]  

P Killian, BB Holmes, AE Takemori, PS Portoghese, and JM Fujimoto

Cold water swim stress- and delta-2 opioid-induced analgesia are modulated by spinal gamma-aminobutyric acidA receptors
J Pharmacol Exp Ther 1995 274: 730-734. [Abstract] [PDF]  

WX Shi, P Nathaniel, and BS Bunney

Ritanserin, a 5-HT2A/2C antagonist, reverses direct dopamine agonist- induced inhibition of midbrain dopamine neurons
J Pharmacol Exp Ther 1995 274: 735-740. [Abstract] [PDF]  

GB Glavin, MA Carlisle, and DD Smyth

Agmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats
J Pharmacol Exp Ther 1995 274: 741-744. [Abstract] [PDF]  

LA Lark, SM Wappel, and JA Weyhenmeyer

Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt- sensitive rats
J Pharmacol Exp Ther 1995 274: 745-751. [Abstract] [PDF]  

DR Taft and KR Sweeney

The influence of protein binding on the elimination of acetazolamide by the isolated perfused rat kidney: evidence of albumin-mediated tubular secretion
J Pharmacol Exp Ther 1995 274: 752-760. [Abstract] [PDF]  

EI Ashforth, DJ Carlile, R Chenery, and JB Houston

Prediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data
J Pharmacol Exp Ther 1995 274: 761-766. [Abstract] [PDF]  

G Pacheco, R Palacios-Esquivel, and DE Moss

Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase
J Pharmacol Exp Ther 1995 274: 767-770. [Abstract] [PDF]  

M Alkondon and EX Albuquerque

Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current
J Pharmacol Exp Ther 1995 274: 771-782. [Abstract] [PDF]  

SM Waters, CS Konkoy, and TP Davis

Neuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation
J Pharmacol Exp Ther 1995 274: 783-789. [Abstract] [PDF]  

A Malmberg and N Mohell

Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides
J Pharmacol Exp Ther 1995 274: 790-797. [Abstract] [PDF]  

M VanRollins

Epoxygenase metabolites of docosahexaenoic and eicosapentaenoic acids inhibit platelet aggregation at concentrations below those affecting thromboxane synthesis
J Pharmacol Exp Ther 1995 274: 798-804. [Abstract] [PDF]  

SS Negus, ER Butelman, MB Gatch, and JH Woods

Effects of morphine and ketorolac on thermal allodynia induced by prostaglandin E2 and bradykinin in rhesus monkeys
J Pharmacol Exp Ther 1995 274: 805-814. [Abstract] [PDF]  

F Ueda, K Ban, and T Ishima

Irsogladine activates gap-junctional intercellular communication through M1 muscarinic acetylcholine receptor
J Pharmacol Exp Ther 1995 274: 815-819. [Abstract] [PDF]  

H Danuser, K Bemis, and KB Thor

Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat
J Pharmacol Exp Ther 1995 274: 820-825. [Abstract] [PDF]  

G Fricker and J Drewe

Enteral absorption of octreotide: modulation of intestinal permeability by distinct carbohydrates
J Pharmacol Exp Ther 1995 274: 826-832. [Abstract] [PDF]  

MJ Marks, AE Bullock, and AC Collins

Sodium channel blockers partially inhibit nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes
J Pharmacol Exp Ther 1995 274: 833-841. [Abstract] [PDF]  

S Rosenzweig-Lipson and JE Barrett

Modification of the behavioral effects of (+/-)BAY k 8644, cocaine and d-amphetamine by L-type calcium channel blockers in squirrel monkeys
J Pharmacol Exp Ther 1995 274: 842-851. [Abstract] [PDF]  

F Stain, MJ Barjavel, P Sandouk, M Plotkine, JM Scherrmann, and HN Bhargava

Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat
J Pharmacol Exp Ther 1995 274: 852-857. [Abstract] [PDF]  

N Ferrara, P Abete, G Ambrosio, P Landino, P Caccese, P Cirillo, A Oradei, GP Littarru, M Chiariello, and F Rengo

Protective role of chronic ubiquinone administration on acute cardiac oxidative stress
J Pharmacol Exp Ther 1995 274: 858-865. [Abstract] [PDF]  

DS Kreiss and I Lucki

Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo
J Pharmacol Exp Ther 1995 274: 866-876. [Abstract] [PDF]  

SW Mamber, AB Mikkilineni, EJ Pack, MP Rosser, H Wong, Y Ueda, and S Forenza

Tubulin polymerization by paclitaxel (taxol) phosphate prodrugs after metabolic activation with alkaline phosphatase
J Pharmacol Exp Ther 1995 274: 877-883. [Abstract] [PDF]  

BB Howe, TJ Halterman, CL Yochim, ML Do, SJ Pettinger, RB Stow, CJ Ohnmacht, K Russell, JR Empfield, and DA Trainor

ZENECA ZD6169: a novel KATP channel opener with in vivo selectivity for urinary bladder
J Pharmacol Exp Ther 1995 274: 884-890. [Abstract] [PDF]  

J Zheng, RA Morrisett, J Zhu, and TD Hexum

Neuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel
J Pharmacol Exp Ther 1995 274: 891-897. [Abstract] [PDF]  

TA Rugsley, MD Davis, HC Akunne, LW Cooke, SZ Whetzel, RG MacKenzie, YH Shih, DH van Leeuwen, SB DeMattos, and LM Georgic

CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects
J Pharmacol Exp Ther 1995 274: 898-911. [Abstract] [PDF]  

LT Meltzer, CL Christoffersen, AE Corbin, FW Ninteman, KA Serpa, JN Wiley, LD Wise, and TG Heffner

CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects
J Pharmacol Exp Ther 1995 274: 912-920. [Abstract] [PDF]  

G Movin-Osswald and M Hammarlund-Udenaes

Prolactin release after remoxipride by an integrated pharmacokinetic- pharmacodynamic model with intra- and interindividual aspects
J Pharmacol Exp Ther 1995 274: 921-927. [Abstract] [PDF]  

JJ Anderson, S Randall, and TN Chase

The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum
J Pharmacol Exp Ther 1995 274: 928-936. [Abstract] [PDF]  

JR Jasper, SR Post, KH Desai, PA Insel, and D Bernstein

Colchicine and cytochalasin B enhance cyclic AMP accumulation via postreceptor actions
J Pharmacol Exp Ther 1995 274: 937-942. [Abstract] [PDF]  

DM Bronstein and JS Hong

Effects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality
J Pharmacol Exp Ther 1995 274: 943-950. [Abstract] [PDF]  

S Milano, P Blower, D Romain, and L Grelot

The piglet as a suitable animal model for studying the delayed phase of cisplatin-induced emesis
J Pharmacol Exp Ther 1995 274: 951-961. [Abstract] [PDF]  

MV Jones, NL Harrison, DB Pritchett, and TG Hales

Modulation of the GABAA receptor by propofol is independent of the gamma subunit
J Pharmacol Exp Ther 1995 274: 962-968. [Abstract] [PDF]  

G Pussard, JP Gascard, I Gorenne, C Labat, X Norel, E Dulmet, and C Brink

Endothelin-1 modulates cyclic GMP production and relaxation in human pulmonary vessels
J Pharmacol Exp Ther 1995 274: 969-975. [Abstract] [PDF]  

MR Ruggieri, MD Colton, P Wang, J Wang, RJ Smyth, MA Pontari, and GR Luthin

Human prostate muscarinic receptor subtypes
J Pharmacol Exp Ther 1995 274: 976-982. [Abstract] [PDF]  

GM Yan, RP Irwin, SZ Lin, M Weller, KA Wood, and SM Paul

Diphenylhydantoin induces apoptotic cell death of cultured rat cerebellar granule neurons
J Pharmacol Exp Ther 1995 274: 983-990. [Abstract] [PDF]  

GC Palmer, EC Cregan, AR Borrelli, EW Harris, ML Stagnitto, P Colombo, FC Kaiser, RJ Murray, RC Griffith, and JC Strand

Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia
J Pharmacol Exp Ther 1995 274: 991-1000. [Abstract] [PDF]  

W Zhu, T Igarashi, H Friedman, and TW Klein

delta 9-Tetrahydrocannabinol (THC) causes the variable expression of IL2 receptor subunits
J Pharmacol Exp Ther 1995 274: 1001-1007. [Abstract] [PDF]  

A Sauter and M Rudin

Strain-dependent drug effects in rat middle cerebral artery occlusion model of stroke
J Pharmacol Exp Ther 1995 274: 1008-1013. [Abstract] [PDF]  

KB Thor and MA Katofiasc

Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat
J Pharmacol Exp Ther 1995 274: 1014-1024. [Abstract] [PDF]  

LA Edwards, LC Read, SJ Nishio, AJ Weir, W Hull, S Barry, D Styne, JA Whitsett, AF Tarantal, and C George-Nascimento

Comparison of the distinct effects of epidermal growth factor and betamethasone on the morphogenesis of the gas exchange region and differentiation of alveolar type II cells in lungs of fetal rhesus monkeys
J Pharmacol Exp Ther 1995 274: 1025-1032. [Abstract] [PDF]  

ERRATUM
J Pharmacol Exp Ther 1995 274: 1033. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.